TAP
58
-2
NWL
44
-4
EOG
58
2
ZTS
47
2
EQIX
60
-2
NAVI
41
-3
PPL
54
2
ALLE
37
5
VLO
40
-2
IR
63
3
UNH
61
6
AKAM
43
3
ADP
64
2
JWN
40
-2
MRO
55
3
INTC
35
-2
URI
53
-2
EW
37
-2
AXP
66
2
GIS
26
3
TAP
58
-2
NWL
44
-4
EOG
58
2
ZTS
47
2
EQIX
60
-2
NAVI
41
-3
PPL
54
2
ALLE
37
5
VLO
40
-2
IR
63
3
UNH
61
6
AKAM
43
3
ADP
64
2
JWN
40
-2
MRO
55
3
INTC
35
-2
URI
53
-2
EW
37
-2
AXP
66
2
GIS
26
3
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

TAK
Takeda Pharmaceutical

Last Price:
13.33
Seasonality Move:
3.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Takeda Pharmaceutical Price Quote

$13.33
+0.04 (+0.3%)
(Updated: November 21, 2024 at 5:55 PM ET)

Takeda Pharmaceutical Key Stats

Sell
20
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$13.21 - $13.48
52-week range:
$12.58 - $15.08
Dividend yield:
4.52%
P/E ratio:
42.83
P/S ratio:
1.43
P/B ratio:
0.89%
Volume:
3.8M
Avg. volume:
1.6M
1-year change:
-5.14%
Market cap:
$42.9B
Revenue:
$29.5B
EPS:
$0.6

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $6B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $306.8M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.5B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 2.37%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 1.91%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 4.01%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.64% 6.41%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 16.01
Upside from Last Price: 20.45%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    196.8M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders